Standard BioTools Inc
LAB1.295USD
-0.005-0.38%
Horário de mercado （ET）Cotações atrasadas em 15 min
490.92MValor de mercado
PerdaP/L TTM
Mais detalhes de Standard BioTools Inc Empresa
Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. The Company's segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. The Company provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company also provides differentiated multi-omics tools for research.
Informações da empresa
Código da empresaLAB
Nome da EmpresaStandard BioTools Inc
Data de listagemFeb 10, 2011
CEODr. Michael Egholm, Ph.D.
Número de funcionários818
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 10
Endereço2 Tower Place
CidadeSOUTH SAN FRANCISCO
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94080
Telefone16502666000
Sitehttps://www.standardbio.com/
Código da empresaLAB
Data de listagemFeb 10, 2011
CEODr. Michael Egholm, Ph.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
157.01K
+151.54%
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
105.09K
-37.30%
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
157.01K
+151.54%
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
105.09K
-37.30%
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Services
17.61M
43.16%
Consumables
14.45M
35.43%
Instruments
7.78M
19.07%
Other revenue
956.00K
2.34%
Por RegiãoUSD
Nome
Receita
Proporção
Americas
18.97M
46.51%
Europe & Middle East & Africa (EMEA)
12.61M
30.90%
Asia-Pacific
9.21M
22.59%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Services
17.61M
43.16%
Consumables
14.45M
35.43%
Instruments
7.78M
19.07%
Other revenue
956.00K
2.34%
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Casdin Capital, LLC
20.03%
Viking Global Investors LP
15.44%
BlackRock Institutional Trust Company, N.A.
5.88%
The Vanguard Group, Inc.
4.52%
Morgan Stanley Investment Management Inc. (US)
2.60%
Other
51.53%
Investidores
Investidores
Proporção
Casdin Capital, LLC
20.03%
Viking Global Investors LP
15.44%
BlackRock Institutional Trust Company, N.A.
5.88%
The Vanguard Group, Inc.
4.52%
Morgan Stanley Investment Management Inc. (US)
2.60%
Other
51.53%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
29.08%
Hedge Fund
27.61%
Investment Advisor
14.98%
Individual Investor
1.52%
Venture Capital
0.62%
Research Firm
0.52%
Bank and Trust
0.22%
Pension Fund
0.12%
Private Equity
0.03%
Other
25.29%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
332
283.42M
74.62%
-28.16M
2025Q1
336
286.88M
75.60%
-24.96M
2024Q4
322
279.84M
75.18%
-22.14M
2024Q3
315
282.67M
78.53%
-14.93M
2024Q2
303
268.49M
74.97%
-14.97M
2024Q1
306
263.03M
71.99%
+131.65M
2023Q4
264
54.09M
66.99%
-14.10M
2023Q3
265
53.37M
67.31%
-13.39M
2023Q2
273
51.56M
65.50%
-19.05M
2023Q1
294
52.71M
66.75%
-21.93M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Casdin Capital, LLC
76.08M
20.03%
--
--
Apr 15, 2025
Viking Global Investors LP
58.65M
15.44%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
22.35M
5.88%
-330.50K
-1.46%
Mar 31, 2025
The Vanguard Group, Inc.
17.17M
4.52%
+69.10K
+0.40%
Mar 31, 2025
Morgan Stanley Investment Management Inc. (US)
9.86M
2.6%
-5.85M
-37.23%
Mar 31, 2025
Geode Capital Management, L.L.C.
7.21M
1.9%
+230.24K
+3.30%
Mar 31, 2025
Long Focus Capital Management LLC
6.70M
1.76%
+6.70M
--
Mar 31, 2025
Tikvah Management LLC
6.55M
1.72%
--
--
Mar 31, 2025
State Street Global Advisors (US)
6.36M
1.67%
+69.13K
+1.10%
Mar 31, 2025
Nikko Asset Management Co., Ltd.
6.23M
1.64%
-384.70K
-5.81%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
Invesco NASDAQ Future Gen 200 ETF
0.54%
ARK Genomic Revolution ETF
0.36%
iShares Micro-Cap ETF
0.08%
iShares Biotechnology ETF
0.05%
iShares Russell 2000 Value ETF
0.03%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Ver Mais
Invesco NASDAQ Future Gen 200 ETF
Proporção0.54%
ARK Genomic Revolution ETF
Proporção0.36%
iShares Micro-Cap ETF
Proporção0.08%
iShares Biotechnology ETF
Proporção0.05%
iShares Russell 2000 Value ETF
Proporção0.03%
iShares Russell 2000 ETF
Proporção0.01%
Global X Russell 2000 ETF
Proporção0.01%
Proshares Ultra Russell 2000
Proporção0.01%
ProShares Hedge Replication ETF
Proporção0.01%
ProShares UltraPro Russell2000
Proporção0.01%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
